IA
IPCI

IFP Advisors’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

IFP Advisors’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1
Closed – – 4279
2017
Q3 		$0 Hold
1
– – ﹤0.01% 4316
2017
Q2 		$0 Hold
1
– – ﹤0.01% 4318
2017
Q1 		$0 Hold
1
– – ﹤0.01% 4241
2016
Q4 		$0 Hold
1
– – ﹤0.01% 4227
2016
Q3 		$0 Hold
1
– – ﹤0.01% 4145
2016
Q2 		$0 Buy
+1
New +$18 ﹤0.01% 4210
2016
Q1 		– Sell
-1
Closed – – 3857
2015
Q4 		$0 Buy
+1
New +$19 ﹤0.01% 3852

Other funds holding IPCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return
VAM
Verity Asset Management Durham, North Carolina $238M AUM 24.8% 1-Year Est. Return

IFP Advisors's IPCI Position: Q4 2017 in Review

IFP Advisors sold out of Intellipharmaceuticals International Inc. (IPCI) in Q4 2017, closing a stake of 1 share.

IFP Advisors first reported a position in IPCI in Q4 2015 and held it in 7 quarters. The position peaked at $0 in Q3 2017. 28 funds tracked by Wall St. Rank hold IPCI as of Q4 2017.

  • IFP Advisors reported no remaining Intellipharmaceuticals International Inc. position as of Q4 2017 after selling out during the quarter.
  • IFP Advisors sold 1 Intellipharmaceuticals International Inc. share in Q4 2017.
  • IFP Advisors first reported a position in Intellipharmaceuticals International Inc. in Q4 2015 and held it in 7 quarters.
  • IFP Advisors's Intellipharmaceuticals International Inc. position peaked at $0 in Q3 2017.
  • 28 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q4 2017.

Based on IFP Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.